235 related articles for article (PubMed ID: 16619469)
1. The long and winding road from Asilomar to Brussels: science, politics and the public in biotechnology and regulation.
Abels G
Sci Cult (Lond); 2005 Dec; 14(4):339-53. PubMed ID: 16619469
[No Abstract] [Full Text] [Related]
2. Transnationalizing recombinant-DNA regulation: between Asilomar, EMBO, the OECD, and the European Community.
Gottweis H
Sci Cult (Lond); 2005 Dec; 14(4):325-38. PubMed ID: 16619468
[No Abstract] [Full Text] [Related]
3. Recombinant regulation: the Asilomar legacy 30 years on.
Hindmarsh R; Gottweis H
Sci Cult (Lond); 2005 Dec; 14(4):299-307. PubMed ID: 16619466
[No Abstract] [Full Text] [Related]
4. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
Krimsky S
Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
[No Abstract] [Full Text] [Related]
5. Asilomar's legacy in Aotearoa New Zealand.
Rogers-Hayden T
Sci Cult (Lond); 2005 Dec; 14(4):393-410. PubMed ID: 16622954
[No Abstract] [Full Text] [Related]
6. Genetically modified survival: red and green biotechnology in Israel.
Prainsack B; Firestine O
Sci Cult (Lond); 2005 Dec; 14(4):355-72. PubMed ID: 16619470
[No Abstract] [Full Text] [Related]
7. Genetic engineering regulation in Australia: an 'archaeology' of expertise and power.
Hindmarsh R
Sci Cult (Lond); 2005 Dec; 14(4):373-92. PubMed ID: 16622953
[No Abstract] [Full Text] [Related]
8. Knowledge and the governance of biotechnology.
Doubleday R
Not Polit; 2001; 17(62):22-33. PubMed ID: 15468484
[No Abstract] [Full Text] [Related]
9. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark.
Baark E; Jamison A
Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912
[No Abstract] [Full Text] [Related]
10. Molecular politics in a global economy.
Wright S
Politics Life Sci; 1996 Sep; 15(2):249-63. PubMed ID: 11654797
[No Abstract] [Full Text] [Related]
11. The recombinant DNA controversy: twenty years later.
Berg P; Singer M
Biotechnology (N Y); 1995 Oct; 13(10):1132-4. PubMed ID: 11644758
[No Abstract] [Full Text] [Related]
12. How to keep out what we don't want: an assessment of 'Sozialverträglichkeit' under the Austrian Genetic Engineering Act.
Seifert F; Torgersen H
Public Underst Sci; 1997 Oct; 6(4):301-27. PubMed ID: 11655383
[No Abstract] [Full Text] [Related]
13. Regulation as facilitation: negotiating the genetic revolution.
Black J
Mod Law Rev; 1998 Sep; 61(5):621-60. PubMed ID: 14518446
[No Abstract] [Full Text] [Related]
14. The governance of human genetics: policy discourse and constructions of public trust.
Jones M; Salter B
New Genet Soc; 2003 Apr; 22(1):21-41. PubMed ID: 15282897
[TBL] [Abstract][Full Text] [Related]
15. Genetics and the law: a scientist's view.
Singer MF
Yale Law Policy Rev; 1985; 3(2):315-35. PubMed ID: 11652467
[No Abstract] [Full Text] [Related]
16. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after.
Barkstrom JE
Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740
[No Abstract] [Full Text] [Related]
17. State biotechnology oversight: the juncture of technology, law, and public policy.
Vito CC
Maine Law Rev; 1993; 45(2):329-83. PubMed ID: 11652701
[No Abstract] [Full Text] [Related]
18. The challenge of biotechnology.
Gore A; Owens S
Yale Law Policy Rev; 1985; 3(2):336-57. PubMed ID: 11652468
[No Abstract] [Full Text] [Related]
19. Threats and promises: negotiating the control of research.
Nelkin D
Daedalus; 1978; 107(2):191-209. PubMed ID: 11645789
[No Abstract] [Full Text] [Related]
20. Living inventions: animal patenting in the United States and Europe.
Nelkin D
Stanford Law Pol Rev; 1992-1993 Winter; 4():203-10. PubMed ID: 11652651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
